Search

Search Results
Results 14121 - 14130 of 17236 for Active treatment
  • Health - 26 Nov 2025
    This platform integrates discovery, profiling, and validation tools to link T-cell receptor diversity with antigen specificity.
  • News - 25 Nov 2025
    For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood pressure and insulin resistance strain the body's vascular and metabolic...
  • Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Cimzia intended for persons living in Australia.
  • Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Briviact Tablet and Oral Solution intended for persons living in Australia.
  • Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Briviact intended for persons living in Australia.
  • Drug - 21 Nov 2025
    Consumer Medicine Information (CMI) about Metomax intended for persons living in Australia.
  • News - 20 Nov 2025
    Higher physical activity in midlife and late life is linked to a substantially lower risk of all-cause and Alzheimer’s dementia. Midlife benefits are strongest for moderate or heavy activity, while...
  • Drug - 18 Nov 2025
    Consumer Medicine Information (CMI) about Zilbrysq intended for persons living in Australia.
  • Health - 17 Nov 2025
    Orforglipron is an emerging oral small-molecule GLP-1 receptor agonist that offers glucose-lowering and weight-loss without injections. Clinical trials show meaningful reductions in A1c and body...
  • Drug - 14 Nov 2025
    Consumer Medicine Information (CMI) about Fintepla intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.